Nonalcoholic Fatty Liver Disease (NAFLD) affects 25% to 45% of US adults
Updated: Jul 25
Nonalcoholic fatty liver disease (NAFLD) or "fatty liver" is common. It affects approximately 75 to 100 million adults in the United States. That is 25% to 45% of all US adults. NAFLD, or fatty liver, is the leading cause of chronic liver disease. This is becoming more so prevalent because of the ongoing epidemic of obesity and metabolic syndrome.
"I hope to add real value to social media and share what my patients ask me about." — Dr. Dooreck
Gut Health ➕ Patient Advocacy with Navigation ➕ Life BalanceIf you were looking for information about Private Healthcare Navigation and Patient Advocacy from Executive Health NavigationClick here for Executive Health Navigation
Having served as doctors for over a decade, we help Family Offices, Private Individuals, Registered Investment Advisors, High-Net-Worth Advisors, and C-Suites navigate the healthcare system for their select clients/families, providing privacy and discretion.
Private Healthcare Navigation and Patient Advocacy when YOU need it mostDid you know?
Approximately "25% to 45% of US adults" have Nonalcoholic fatty liver disease (NAFLD) or "fatty liver."
NAFLD is the liver (hepatic) manifestation of the metabolic syndrome. According to the Mayo Clinic, "Metabolic syndrome is a cluster of conditions that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes. These conditions include increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels."
What is Nonalcoholic fatty liver disease (NAFLD)?
Nonalcoholic fatty liver disease (NAFLD) is when there is a presence of at least 5% hepatic steatosis (fat) on liver biopsy without evidence of hepatocellular injury. Risk factors of NAFLD are insulin resistance, obesity, and, as mentioned above, metabolic syndrome.
What is Nonalcoholic steatohepatitis (NASH)?
Nonalcoholic steatohepatitis (NASH) is a subset of NAFLD. It is a more progressive and more advanced form of fatty liver disease. There is a greater risk of fibrosis (scarring) and eventual cirrhosis (end-stage liver disease) that carries complications that can lead to high morbidity and mortality (death).
Body Mass Index (BMI)
"Current estimates suggest that approximately 68% of all US adults meet body mass index criteria for being overweight or obese."
What is the big deal of having "fatty liver"?
Because "fatty liver" can progress from NAFLD to NASH. Then the risk of liver-specific morbidity (complications) and mortality (death) increases by 50 to 80 in patients with advanced fibrosis related to NASH. For this reason, correctly diagnosing and staging is critical for disease monitoring and prognosis.
Diagnosing NAFLD
A liver biopsy is the gold standard. However, noninvasive means include ultrasound, blood testing, ultrasound elastography, and other radiographic options, like MRI studies. The early diagnosis and a sense of the severity of hepatic steatosis (fatty liver) may prompt further evaluation and more aggressive management of metabolic comorbidities, such as obesity, diabetes, etc.
Treatment of NAFLD
The US Food and Drug Administration has not approved any NAFLD-specific drug treatment. Nor is there any therapy for the management of NASH. There are ongoing clinical trials.
The only treatment is lifestyle interventions such as a balanced diet, weight loss, and healthy forms of regular exercise. Weight loss of at least 10% is the first goal. Studies highlight the underlying and actual importance of diet in managing fatty liver or NAFLD.
What do I do if I have NAFLD or "fatty liver"?
The only treatment is lifestyle interventions such as a balanced diet, weight loss, and healthy forms of regular exercise.
Personally
I eat a high-fiber, mostly plant-based 🌱 diet, no red meat, drink 4 liters of water a day, exercise, and am focused on keeping nutrition simple. I am sharing what works for me and what I routinely recommend to my patients.
"Balance. Portion control. Keep nutrition simple. Eat Smart. Eat Healthy. 🌱 🌾 🌿"
Gut Health ➕ Patient Advocacy with Navigation ➕ Life Balance
If you were looking for information about Private Healthcare Navigation and Patient Advocacy from Executive Health NavigationClick here for Executive Health Navigation✴ Connect with Dr. Dooreck on LinkedIn, where he focuses his sharing on Health, Diet, Nutrition, Exercise, Lifestyle, and Balance.
gastroenterology | colonoscopy doctor | colonoscopy and gastroenterology services | gastro doctor | gi doctor | gastrointestinal diagnostic centers | public health